39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

This study aims to determine the availability and measure the financial accessibility to drugs for the three most frequent digestive pathologies: cirrhosis, duodenal ulcer and gastritis, following the method of the World Health Organization and Health Action International. At the end of the survey, the average availability of the 18 drugs studied was all below 50%. For specialties, the average availability was 32.43% (pharmacies); 24.95% (hospital pharmacy) and 18% (wholesalers). For generics, it was 36.34% (dispensaries); 33.33% (hospital pharmacy) and 30.55% (wholesalers). For financial…mehr

Produktbeschreibung
This study aims to determine the availability and measure the financial accessibility to drugs for the three most frequent digestive pathologies: cirrhosis, duodenal ulcer and gastritis, following the method of the World Health Organization and Health Action International. At the end of the survey, the average availability of the 18 drugs studied was all below 50%. For specialties, the average availability was 32.43% (pharmacies); 24.95% (hospital pharmacy) and 18% (wholesalers). For generics, it was 36.34% (dispensaries); 33.33% (hospital pharmacy) and 30.55% (wholesalers). For financial accessibility, it was more reasonable with generic drugs than with specialties. The availability of drugs for the main digestive pathologies was low and their accessibility was poor due to the non-availability of their generic equivalents and their excessive cost in private pharmacies.
Autorenporträt
RAHARIJAONA Ranja Arnaud, estudiante de farmacia en la Facultad de Medicina de la Universidad de Antananarivo.